Heart Tronics (HRTT) Stock Analysis & Winston Score

Heart Tronics, Inc. is a small medical device company that focused on developing heart monitoring technology. Its core product was the Fidelity 100, a portable electrocardiogram (ECG) device designed to detect heart problems outside of a hospital setting. The intended customers were patients, doctors, and healthcare providers who needed affordable cardiac monitoring tools. The company attempted to sell its devices directly and through distribution partners, primarily targeting the United States market. However, Heart Tronics has shown essentially no revenue and no gross profit, which signals the business never reached meaningful commercial scale. The financial data — including a near-zero market cap and zero margins — suggests the company is largely inactive or a shell, and investors should be aware that companies at this stage carry extreme risk of total loss of investment, including potential delisting or dissolution.